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Interventricular Differences in b-Adrenergic Responses in the
Canine Heart: Role of Phosphodiesterases
Cristina E. Molina, PhD;* Daniel M. Johnson, PhD;* Hind Mehel, PhD; Roel L. H. M. G. Sp€atjens, BS; Delphine Mika, PhD; Vincent
Algalarrondo, MD; Zeineb Haj Slimane, PhD; Patrick Leche^ne, BS; Najah Abi-Gerges, PhD; Henk J. van der Linde, BS; Jero^me Leroy, PhD;
Paul G. A. Volders, MD, PhD; Rodolphe Fischmeister, PhD; Gregoire Vandecasteele, PhD
Background-—RV and LV have different embryologic, structural, metabolic, and electrophysiologic characteristics, but whether
interventricular differences exist in b-adrenergic (b-AR) responsiveness is unknown. In this study, we examine whether b-AR
response and signaling differ in right (RV) versus left (LV) ventricles.
Methods and Results-—Sarcomere shortening, Ca2+ transients, ICa,L and IKs currents were recorded in isolated dog LV and RV
midmyocytes. Intracellular [cAMP] and PKA activity were measured by live cell imaging using FRET-based sensors. Isoproterenol
increased sarcomere shortening 10-fold and Ca2+-transient amplitude 2-fold in LV midmyocytes (LVMs) versus 25-fold and
3-fold in RVMs. FRET imaging using targeted Epac2camps sensors revealed no change in subsarcolemmal [cAMP], but a 2-fold
higher b-AR stimulation of cytoplasmic [cAMP] in RVMs versus LVMs. Accordingly, b-AR regulation of ICa,L and IKs were similar
between LVMs and RVMs, whereas cytoplasmic PKA activity was increased in RVMs. Both PDE3 and PDE4 contributed to the b-AR
regulation of cytoplasmic [cAMP], and the difference between LVMs and RVMs was abolished by PDE3 inhibition and attenuated by
PDE4 inhibition. Finally LV and RV intracavitary pressures were recorded in anesthetized beagle dogs. A bolus injection of
isoproterenol increased RV dP/dtmax5-fold versus 3-fold in LV.
Conclusion-—Canine RV and LV differ in their b-AR response due to intrinsic differences in myocyte b-AR downstream signaling.
Enhanced b-AR responsiveness of the RV results from higher cAMP elevation in the cytoplasm, due to a decreased degradation by
PDE3 and PDE4 in the RV compared to the LV. ( J Am Heart Assoc. 2014;3:e000858 doi: 10.1161/JAHA.114.000858)
Key Words: cAMP • dog • heart ventricles • phosphodiesterases • b-adrenergic stimulation
T he sympathetic nervous system is responsible foradaptation of cardiac output to stress and physical
exercise. This “ﬁght-or-ﬂight” response is mediated primarily
by noradrenaline and adrenaline acting on b-adrenergic
receptors (b-ARs) at the surface of cardiac myocytes. b-ARs
are coupled through Gas to adenylyl cyclases (AC) and
the generation of cAMP, which in turn activates the
cAMP-dependent protein kinase (PKA). PKA then phospho-
rylates key proteins involved in excitation-contraction
coupling (ECC) including sarcolemmal L-type Ca2+ channels
(ICa,L), ryanodine receptors (RyR2), phospholamban, and
troponin I.1 In addition, PKA phosphorylates slowly activat-
ing delayed rectiﬁer K+ (IKs) channels to control cardiac
repolarization.2
The levels of cAMP and thus the degree of PKA activation
are ﬁnely regulated by cyclic nucleotide phosphodiesterases
(PDEs) that degrade the second messenger into 50-AMP.
Cardiac PDEs degrading cAMP belong to 5 families (PDE1-4
and PDE8), which can be distinguished by distinct enzymatic
properties and pharmacology.3 In rodents, PDE3 and PDE4
are the major contributors to the total cAMP-hydrolytic
activity4,5 and PDE4 is dominant to modulate b-AR regulation
of cAMP levels.6–9 Multiple PDE4 variants associate with b-
ARs,10–12 RyR2,13 SERCA2,14,15 ICa,L,
16 and IKs
17 to exert local
control of ECC. In larger mammals, PDE3 activity is dominant
in microsomal fractions18–20 and PDE3 inhibitors exert a
potent positive inotropic effect.21 Selective inhibition of PDE3
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with milrinone has been shown to improve cardiac contrac-
tility in patients with congestive heart failure.22 The role of
PDE4 is less well deﬁned but evidence is emerging that PDE4
may also play an important role in these species. In the canine
heart, a large PDE4 activity is found in the cytoplasm18 but
PDE4 is also present in microsomal fractions, where it
accounts for 20% of the activity.19 Recent studies have
indicated that PDE4 is expressed in human ventricle where,
similar to rodents, it associates with b-ARs, RyR2 and
phospholamban.5,13 Moreover, PDE4 controls ECC and ar-
rhythmias in human atrium.23
The right (RV) and left (LV) ventricles originate from
different progenitor cells24,25 and differ in several important
ways. Both ventricles have different mass (under normal
conditions LV mass is 6-fold RV mass), volume, morpho-
logies and pressures.26,27 Electrical heterogeneity has been
well characterized between ventricular epicardial, endocar-
dial and midmyocardial layers.28–31 Although less studied,
different electrophysiological properties were also reported
between the 2 ventricles. In rats and dogs, the action
potential (AP) is shorter in the RV than in the LV.32,33 In
dogs, the notch in phase 1 of the AP is deeper in the RV
than the LV.33,34 These differences are related to larger
repolarizing K+ currents, Ito and IKs in dog RV.
33,34 In this
species, a larger RV IKs correlates with a higher expression of
KCNQ1 and KCNE1, the principal and auxiliary subunit of the
IKs channel, respectively.
35 Regional heterogeneity between
the LV and the RV may also exist for ATP-activated K+
current, IKATP.
36,37
In contrast to these electrophysiological studies, a recent
proteomic study reported no difference in the expression level
of >600 proteins between the RV and the LV from pig and
rabbit. Most of these were contractile/structural proteins,
oxidative phosphorylation components, and enzymes from
intermediary metabolism. No plasma membrane voltage-gated
ion channels were analyzed, but a few major Ca2+ handling
proteins (SERCA2, RyR2) and signal transduction components
(Ca2+/Calmodulin kinase IId, PKA type I and II) showed no
variation in expression level.38
These studies raise the question of whether functional
differences between the LV and the RV are limited to
electrophysiological features or extend to other aspects of
ventricular function. Surprisingly, only limited information is
available concerning ECC and its neurohumoral regulation in
RV versus LV in the healthy heart. However, a previous report
in rats has shown that, despite similar interventricular
expression levels, a higher proportion of the total SERCA2a
pool is associated with phospholamban in RV myocytes (RVM)
compared with LV myocytes (LVM), resulting in lower Ca2+
reuptake rate and prolonged Ca2+ transients.39 In mice,
opposing inotropic responses to a1-AR stimulation have been
reported, and were attributed to different effects on myoﬁl-
ament Ca2+ sensitivity.40 In humans, recent clinical studies
indicate that ventricular load increases more for the RV than
the LV during exercise41 and this may reﬂect, at least in part,
relative differences in maximal pulmonary-arterial versus
aortic pressure. It is currently unclear whether interventricular
differences exist in the sympathetic responsiveness of the
human heart.
In canine, while the absolute dP/dt values are far greater
in LV than in RV, stimulation of the cardiac sympathetic
nerves induces greater relative changes in contractile force
in the RV than in the LV.42 These changes are insensitive to
a1-AR blockade by phentolamine, implicating differences in
b-AR response.43 However, several studies reported no
difference in b-AR density, AC activity and its activation
by catecholamines between RV and LV under normal
conditions.44–49
Intrigued by these apparent differences, we examined the
b-AR regulation of cardiac contractility in dog RV and LV in
isolated myocytes and in vivo. Our data reveal enhanced
sensitivity of the RV to b-AR stimulation, and provide evidence
that PDE3 and PDE4 shape distinct compartmentalized cAMP
signals that underlie interventricular dispersion in b-AR
stimulation.
Methods
This investigation conformed to the Guide for the Care and
Use of Laboratory Animals published by the US National
Institutes of Health (NIH Publication No. 85-23, revised 1996).
Animal handling was in accordance with the European
Directive for the Protection of Vertebrate Animals Used for
Experimental and Other Scientiﬁc Purposes (86/609/EU).
The study was conducted in accordance with the Declaration
of Helsinki principles, and approved by the Ethical Commit-
tees of our institutions.
In Vivo Experiments
General anesthesia was induced in 4 beagle dogs (3 F/
1 mol/L; average weight 111 kg) by lofentanil (0.075 mg/
kg body weight i.v.), scopolamine (0.015 mg/kg), succinyl-
choline (1.0 mg/kg), and subsequent hourly slow injections of
fentanyl (0.025 mg/kg i.v.) and continuous infusion of
etomidate (1.5 mg/kg per hour). Dogs were ventilated with
30% oxygen in pressurized air to normocapnia. The body
temperature was kept at 37°C with a heated water mattress.
ECG standard lead II was continuously recorded. Under
closed-chest conditions, LV and RV intracavitary pressures
were recorded simultaneously with high-ﬁdelity catheter-tip
micromanometers introduced via the femoral artery and vein
(Gaeltec Ltd, Dunvegan, UK and Millar Instruments Inc). In
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each animal a bolus injection of isoproterenol (2.5 lg/kg)
was administered and repeated twice, with each next infusion
given after baseline values had been stably reestablished.
Cell-Isolation Procedure
Adult female beagle dogs were used for myocyte isolations.
A total of 12 dogs were included in the study. Anesthesia was
induced with 45 mg/kg of pentobarbital. Once full anesthesia
was reached, the chest was opened via a left thoracotomy and
the heart was excised and placed in an O2-gassed, Ca
2+-free
standard buffer solution at approximately 4°C. The cell-
isolation procedure was the same as previously described.33
Brieﬂy, both the left-anterior-descending and right coronary
arteries were cannulated and perfused simultaneously. After
20 minutes of collagenase perfusion and subsequent wash-
out of the enzyme, the epicardial surface layer was removed
from wedges of both the LV and RV until a depth of ≥3 mm
was reached. Softened tissue samples were collected from the
midmyocardial layer underneath, while contamination with the
endocardium was avoided. Samples were gently agitated,
ﬁltered, and washed. Midmyocytes were stored at room
temperature in standard buffer solution (vide infra) and only
quiescent rod-shaped cells with clear cross-striations and
without granulation were used for the experiments. Cells were
used within 48 hour of isolation.
Adenoviral Infection of Dog Ventricular Myocytes
Isolated cells were suspended in minimal essential medium
(MEM: M 4780; Sigma) containing 1.2 mmol/L Ca2+, 2.5%
fetal bovine serum (FBS; Invitrogen, Cergy-Pontoise), 1%
penicillin-streptomycin, 2% HEPES (pH 7.6) and plated on
35 mm, laminin-coated culture dishes (10 lg/mL laminin,
2 hour) at a density of 104 cells per dish. Dishes were kept in
an incubator (95% O2, 5% CO2, 37°C) for 2 hours. Then the
medium was replaced by 400 lL of FBS-free MEM containing
adenoviruses encoding for the cytoplasmic cAMP sensor
Epac2-camps50 at a multiplicity of infection (MOI) of
1000 pfu/cell, the plasma-membrane targeted pmEpac2-
camps51 at an MOI of 700 pfu/cell and the cytoplasmic
PKA sensor AKAR3-NES52 at a MOI of 1000 pfu/cell.
ICa,L Recordings
The whole-cell conﬁguration of the patch-clamp technique
was used to record ICa,L. Patch-electrode resistance was
between 1 and 2 MΩ when ﬁlled with internal solution
containing (in mmol/L): CsCl 118, EGTA 5, MgCl2 4,
Na2phosphocreatine 5, Na2ATP 3.1, Na2GTP 0.42, CaCl2
0.062 (pCa 8.5), HEPES 10, adjusted to pH 7.3 with CsOH.
Extracellular Cs+-Ringer solution contained (in mmol/L): CaCl2
1.8, MgCl2 1.8, NaCl 107.1, CsCl 20, NaHCO3 4, NaH2PO4
0.8, D-glucose 5, sodium pyruvate 5, HEPES 10, adjusted to
pH 7.4 with NaOH. The cells were depolarized every
8 seconds from 50 to 0 mV during 400 ms. The use of
50 mV as holding potential allowed the inactivation of
voltage-dependent Na+ currents. K+ currents were blocked by
replacing all K+ ions with external and internal Cs+. Ampliﬁers
RK-400 (Bio-Logic) or Axopatch 200B (Axon Instruments, Inc.)
were used for voltage clamping and acquisition. Currents were
analogue ﬁltered at 3 kHz and digitally sampled at 10 kHz
using a 12-bit analogue-to-digital converter (DT2827; Data
Translation) connected to a compatible PC or a Digidata
1440A interface connected to a computer equipped with
pClamp 10 software (Axon Instruments, Inc.). The maximal
amplitude of whole-cell ICa,L was measured as previously
described.53 Currents were not compensated for capacitance
and leak currents. These experiments were performed at
room temperature.
IKs Recordings
The whole-cell conﬁguration of the patch-clamp technique
was also used to record IKs. Patch electrodes had a resistance
between 0.5 and 2 MO when ﬁlled with internal solution
containing (in mmol/L): K-aspartate 125, KCl 20, MgCl2 1.0,
MgATP 5, HEPES 5 and EGTA 10, pH 7.2 with KOH. The
external solution had the following composition (mmol/L):
NaCl 145, KCl 4.0, CaCl2 1.8, MgCl2 1.0, glucose 11 and
HEPES 10, pH 7.4 with NaOH at 37°C. During the recordings,
KCl was omitted from the external solution to increase IKs
amplitude, which occurs through changes in the concentra-
tion gradient, while leaving the kinetics of IKs activation and
deactivation uninﬂuenced.54 ICa,L was blocked with nifedipine
(5 lmol/L) and IKr with dofetilide (1 lmol/L). The myocytes
were depolarized from a holding potential of 50 mV to
+50 mV for 3 seconds, with the tail currents on repolarization
to 0 mV quantiﬁed as IKs. Ten baseline pulses were recorded
followed by 3 pulses during brief (15 seconds) stimulation
with Iso (PDE inhibitor) and this was followed by a further 50
pulses during perfusion with 0 mmol/L K+ (PDE inhibitor).
Fast solution changes were achieved with the complete VC-6
fast-step perfusion system (Harvard Apparatus) together with
a multibarrel glass pipette that was positioned 50 lm from
the cell during drug application.
Recordings of Ca2+ Transients and Sarcomere
Shortening
Myocytes were loaded with 5 lmol/L Fura-2 AM (Invitrogen)
during 15 minutes at room temperature and then washed
with Ringer solution containing (in mmol/L): NaCl 121.6, KCl
5.4, MgCl2 1.8, CaCl2 1.8, NaHCO3 4, NaH2PO4 0.8, D-glucose
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5, Na-pyruvate 5, HEPES 10, adjusted to pH 7.4 with NaOH.
The loaded cells were ﬁeld-stimulated (5 V, 4 ms) at a
frequency of 0.3 Hz. Then, sarcomere length and Fura-2 ratio
(measured at 512 nm upon excitation at 340 nm and
380 nm) were simultaneously recorded using an IonOptix
System (IonOptix). Cell contraction was assessed as the
percentage of sarcomere shortening, which is the ratio of
twitch amplitude (difference of end-diastolic and peak systolic
sarcomere lengths) to end-diastolic sarcomere length. Ca2+-
transient amplitude was assessed by the percentage of
variation of the Fura-2 ratio, by dividing the twitch amplitude
(difference of end-diastolic and peak systolic ratios) to end-
diastolic ratio. All parameters were calculated ofﬂine with
dedicated software (IonWizard 6x, IonOptix). These experi-
ments were performed at room temperature.
FRET Measurements
The same Ringer solution as described above for Ca2+
transients and cell-shortening measurements was used in
these experiments. Images were captured every 5 seconds
using the 409 oil immersion objective of a Nikon TE 300
inverted microscope connected to a software-controlled (Meta-
ﬂuor, Molecular Devices, Sunnyvale, CA) cooled charge coupled
(CCD) camera (Sensicam PE; PCO). Cyan ﬂuorescent protein
(CFP) was excited during 150 to 300 ms by a Xenon lamp
(100 W; Nikon) using a 440/20BP ﬁlter and a 455LP dichroic
mirror. Dual-emission imaging of CFP and yellow ﬂuorescent
protein (YFP) was performed using an Optosplit II emission
splitter (Cairn Research) equipped with a 495LP dichroic mirror
and BP ﬁlters 470/30 and 535/30, respectively. A region of
interest including the entire cell was used for measurement of
average CFP and YFP intensity. CFP and YFP intensities were
background corrected and the YFP emission was corrected for
CFP bleed through. The ratio of CFP over corrected YFP was
used as an index of cAMP concentration.
Reagents
Cilostamide was from Tocris Bioscience and Ro 20-1724 was
from Calbiochem. Unless speciﬁed, all other drugs were from
Sigma-Aldrich. Isoproterenol (Iso) was ﬁrst dissolved in
distilled water containing 30 lmol/L ascorbic acid and then
kept in the dark at 4°C until use.
Data Analysis and Statistics
All results are expressed as meanSEM. For statistical
evaluation the paired and unpaired Student’s t test were used,
and a difference was considered statistically signiﬁcant when
P<0.05. Levene and Shapiro-Wilke tests were carried out in all
the experiments in order to conﬁrm homogeneity and normal
distribution. Higher-order ANOVA without the assumption of
sphericity (Greenhouse-Geisser correction) was used for
comparison of multiple effects and to check for the absence
of correlation within animals. Sidak Adjustment Multiple
Comparisons was used to evaluate the signiﬁcance of
measurements over time.
Results
Sarcomere Shortening and Ca2+-Transient
Measurements in Response to b-AR Stimulation
in RV and LV Midmyocytes
Sarcomere shortening and Ca2+ transients were simulta-
neously measured in Fura-2-loaded RVMs and LVMs obtained
from the same hearts and paced at 0.3 Hz. There was no
signiﬁcant difference in basal sarcomere length, basal sarco-
mere shortening, basal Fura-2 ratio and basal Ca2+-transient
amplitude (Table). As shown by the individual traces of
Figures 1A and 1B, a pulse application of Iso (100 nmol/L,
15 seconds) increased the amplitude of sarcomere shorten-
ing and Ca2+ transient in both LVMs and RVMs, but these
effects were exacerbated in RVMs. Indeed, on average Iso
increased sarcomere shortening by 25-fold in RVMs versus
10-fold in LVMs and increased Ca2+ transients 3-fold in
RVMs versus 2-fold in LVMs (Figures 1C and 1D). The effect
of Iso also lasted longer in RVMs than in LVMs, as indicated
by the time to half-maximal recovery (t1/2off) of sarcomere
shortening (7911 seconds in RVMs versus 543 seconds
in LVMs) and Ca2+ transient (827 seconds in RVMs versus
496 seconds in LVMs) (Figures 1E and 1F). Thus, b-AR
stimulation of ECC was more efﬁcient in dog RVMs versus
LVMs.
Table. Basal Parameters Measured in RVMs and LVMs
RVMs n LVMs n
Contraction
SL, lm 1.740.01 20 1.720.01 18
DL, % 1.300.27 20 1.230.20 18
Calcium
Fura-2 ratio 4.930.28 20 4.660.27 18
DR (%) 8.310.84 20 9.001.01 18
Electrophysiology
Cell capacitance, pF 138.73.8 107 132.94.03 105
ICa,L density, pA/pF 2.90.2 89 3.30.2 92
IKs density, pA/pF 1.10.2 18 0.80.1 (P<0.05) 13
LVM indicates left ventricle myocyte; RVM, right ventricle myocyte; SL, sarcomere
length.
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b-AR Regulation of Cytoplasmic cAMP Signals and
PKA Activity in RV and LV Midmyocytes
Because b-AR stimulation of ECC involves cAMP mobilization,
this second messenger was measured in intact LVMs and
RVMs by ﬂuorescence resonance energy transfer (FRET) using
the cytoplasmic sensor Epac2-camps.50 Figure 2A shows
pseudocolor images illustrating the percent increase of the
CFP/YFP ratio 1 minutes and 3 minutes after application of
Iso (100 nmol/L, 15 seconds) in a LVM and a RVM expressing
Epac2-camps. As shown in the inset graph of Figure 2B, there
was no difference in the basal FRET ratio between LVMs and
RVMs. At 1 minute after application of Iso, the CFP/YFP ratio
increased to a greater extent in RVMs than in LVMs. On
average, Iso led to a transient increase in the CFP/YFP ratio
that was 2-fold higher in RVMs versus LVMs (P<0.001)
reﬂecting enhanced cytoplasmic cAMP accumulation in RVMs
(Figure 2B). Because PKA is the primary target of cAMP for
short-term regulation of ECC, cytoplasmic PKA activity was
monitored using the PKA FRET sensor AKAR3-NES.52 As with
Epac2-camps, there was no signiﬁcant difference in the
average basal FRET ratio (inset graph of Figure 2D). As shown
in the pseudocolor images illustrating the relative effect of Iso
(100 nmol/L, 15 seconds) in Figure 2C and on the average
time course of Figure 2D, although the maximal increase in
YFP/CFP ratio was identical at 1 minute, the signal decayed
faster in LVMs than RVMs and became signiﬁcantly higher in
RVMs than LVMs after 2 minutes. This indicates that
cytoplasmic PKA activity was higher in RVMs than in LVMs
in response to b-AR stimulation. The lack of difference in the
YFP/CFP ratio at the beginning of the stimulation was most
likely due to saturation of the AKAR3-NES sensor at this
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Figure 1. b-AR regulation of ECC in LV and RV midmyocytes. A and B, Raw traces of sarcomere shortening (A) and Ca2+ transients
(B) recorded in Fura-2 loaded LVMs and RVMs paced at 0.3 Hz at baseline (grey) and at the peak of pulse isoproterenol stimulation (Iso
100 nmol/L, 15 seconds). C and D, Average maximal effect of Iso on sarcomere shortening (C) and Ca2+ transient amplitude (D) in LVMs (n=10
cells from 4 dogs) and RVMs (n=12 cells from 4 dogs). E and F, Decay kinetics of the b-AR response estimated by the time to 50% decrease (t1/
2off) of sarcomere-shortening amplitude (E) and Ca
2+-transient amplitude (F). The bar graphs indicate mean+SEM. Statistically signiﬁcant
differences between LVMs and RVMs are indicated by *, P<0.05. AR indicates adrenergic; ECC, excitation-contraction coupling;
LV, left ventricle; LVM, left ventricular myocyte; RV, right ventricle; RVM, right ventricle myocyte.
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concentration of Iso, as indicated by the lack of a sharp peak in
RVMs and by previous experiments in rat ventricular myocytes
showing that a 40% change in YFP/CFP represents the
maximal FRET change that can be obtained with this sensor.55
b-AR Regulation of Subsarcolemmal cAMP, ICa,L
and IKs in RV and LV Midmyocytes
Because subsarcolemmal cAMP plays an important role in
ECC, we next used a plasma-membrane targeted version of
Epac2-camps (pmEpac2-camps51) to monitor cAMP specif-
ically in this compartment. To our surprise, comparison of
LVMs and RVMs revealed no difference in subsarcolemmal
cAMP ([cAMP]pm) generated by b-AR stimulation with an Iso
pulse. Indeed, neither the maximal cAMP elevation nor its
decay kinetics was different between LVMs and RVMs
(Figure 3A). We next wondered whether the same was true
for the major sarcolemmal targets of the b-AR/cAMP/PKA
pathway, ICa,L and IKs. As shown in the Table, there was
no difference in basal ICa,L density between RVMs and LVMs.
A pulse stimulation with Iso (100 nmol/L, 15 seconds)
resulted in a similar transient increase of ICa,L between
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Figure 2. RV midmyocytes display enhanced cAMP accumulation and PKA activity in response to b-AR
stimulation. A, Pseudocolor images of a dog LVM (upper images) and a dog RVM (lower images) expressing
the cytoplasmic cAMP FRET sensor Epac2-camps. Illustrated are the percent increases of the CFP/YFP
ratio over baseline at 1 minute and at 3 minutes after Iso (100 nmol/L, 15 seconds) stimulation.
B, Average cytoplasmic cAMP accumulation elicited by Iso pulse stimulation in RVMs (n=36 cells from 6
dogs) and LVMs (n=37 cells from 6 dogs). Inset indicates the basal FRET ratio in LVMs and RVMs. C,
Pseudocolor images of a dog LVM (upper images) and a dog RVM (lower images) expressing the cytoplasmic
PKA sensor AKAR3-NES. Illustrated is the percent increase of the YFP/CFP ratio over basal at 1 minute and
at 3 minutes after the Iso pulse stimulation. D, Average PKA activation elicited by Iso pulse stimulation in
RVMs (n=5 cells from 1 dog) and LVMs (n=4 cells from 1 dog). Inset indicates the basal FRET ratio in LVMs
and RVMs. Statistically signiﬁcant differences between LVMs and RVMs are indicated by *, P<0.05. AR
indicates adrenergic; CFP, cyan ﬂuorescent protein; FRET, ﬂuorescence resonance energy transfer; LV, left
ventricle; LVM, left ventricular myocyte; RV, right ventricle; RVM, right ventricle myocyte; PKA, protein
kinase A; YFP, yellow ﬂuorescence protein.
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LVMs and RVMs, both in terms of amplitude and duration
(Figure 3B). In contrast to ICa,L, basal IKs density was
higher in RVMs than LVMs (Table), which is consistent with
earlier ﬁndings.33 However, pulse b-AR stimulation
increased IKs to similar degrees in LVMs and RVMs
(Figure 3C). These results indicate that (1) differences in
b-AR cAMP signals between LVMs and RVMs are compart-
ment-speciﬁc and (2) the increased stimulation of ECC by
A
B
C
Figure 3. b-AR regulation of subsarcolemmal cAMP, ICa,L and IKs in LV and RV midmyocytes. A, left,
average time-courses of Iso (100 nmol/L, 15 seconds)-induced subsarcolemmal cAMP signals measured
with pmEpac2-camps in RVMs (n=13 from 3 dogs) and LVMs (n=7 from 3 dogs). Right, bar graphs
comparing average maximal amplitude and time to 50% decrease (t1/2off) of the cAMP response. B, left,
average time-courses of ICa,L following Iso (100 nmol/L, 15 seconds) stimulation in RVMs (n=22 from 7
dogs) and LVMs (n=25 from 7 dogs). Right, bar graphs comparing average maximal amplitude and time to
50% decrease (t1/2off) of the ICa,L response. C, left, average time-course of IKs response to Iso (100 nmol/L,
15 seconds) in RVMs (n=8 from 3 dogs) and LVMs (n=8 from 6 dogs). Right, bar graphs comparing average
maximal amplitude and time to 50% decrease (t1/2off) of the IKs response. AR indicates adrenergic; cAMP,
cyclic adenosine monophosphate; ICa,L, L-type Ca
2+ channel current; IKs, slow delayed rectiﬁer K+ current;
LV, left ventricle; LVM, left ventricular myocyte; RV, right ventricle; RVM, right ventricle myocyte.
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Iso in RVMs does not involve up-regulation of ICa,L or down-
regulation of IKs.
PDE3 and PDE4 Shape Distinct b-AR cAMP
Signals in RVMs and LVMs
We next investigated whether phosphodiesterases (PDEs) are
involved in the differences in cytoplasmic cAMP accumulation
observed between RVMs and LVMs upon b-AR stimulation.
We ﬁrst tested the implication of PDE3, because of its critical
importance for the control of cardiac contractility in dog.21
Thus, myocytes expressing Epac2-camps were challenged
with Iso (100 nmol/L, 15 seconds) in the presence of the
speciﬁc PDE3 inhibitor cilostamide (Cil, 1 lmol/L), and the
inhibitor was maintained during Iso washout. Figure 4A shows
that Cil doubled the maximal amplitude of the Iso-induced
cAMP transient in LVMs, while having little effect in RVMs. Cil
also profoundly impaired cAMP recovery in both LVMs and
RVMs, as indicated by the 3-fold increase in time to half
maximal decay (t1/2off) values (Figure 4A). We next tested the
implication of PDE4, which represents the major soluble
cAMP-PDE activity in dog ventricle18 by using the speciﬁc
PDE4 inhibitor Ro-201724 (Ro, 10 lmol/L). Figure 4B shows
that Ro induced a 3-fold increase in the amplitude of the
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Figure 4. Regulation of b-AR cytoplasmic cAMP signals by PDE3 and PDE4 in LVMs and RVMs. A, left, average time course of cAMP levels
measured in the cytoplasm with Epac2-camps following b-AR stimulation with Iso (100 nmol/L, 15 seconds) alone (gray and black lines, data
from Figure 3B) or during administration of the PDE3 inhibitor cilostamide (Cil, 1 lmol/L, white circles: LVMs, n=13 from 3 dogs; black circles:
RVMs, n=17 from 7 dogs). Right, Bar graphs representing the average maximal amplitude and time to 50% recovery (t1/2off) of the cytoplasmic
cAMP transients induced by Iso alone or Iso with Cil in LVMs (n=13) and RVMs (n=17). B, left, average time course of cytosolic cAMP levels
following b-AR stimulation with Iso (100 nmol/L, 15 seconds) alone or during administration of the PDE4 inhibitor Ro 20-1724 (Ro, 10 lmol/L;
white circles: LVMs, n=21 from 6 dogs; black circles: RVMs, n=24 from 5 dogs). Right, bar graphs representing the average maximal amplitude
and time to 50% recovery (t1/2off) of the cAMP transients induced by Iso alone or Iso with Ro in LVMs (n=21) and LVMs (n=24). PDE inhibitors
were added to the Iso solution and in the washout solution. Symbols and bar graphs indicate the meanSEM. Statistical difference between Iso
alone and Iso+PDE inhibitor in LVMs and RVMs is indicated as *, P<0.05; ***, P<0.001. AR indicates adrenergic; cAMP, cyclic adenosine
monophosphate; LV, left ventricle; LVM, left ventricular myocyte; PDE, phosphodiesterase; RV, right ventricle; RVM, right ventricle myocyte.
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cAMP transient elicited by Iso in LVMs and a 2-fold increase in
RVMs. PDE4 inhibition also signiﬁcantly delayed cAMP
recovery, as demonstrated by a 2.5-fold increase in time-
to-half-maximal decay (t1/2off) values. Thus, PDE3 and PDE4
regulate cytoplasmic cAMP accumulation upon b-AR stimula-
tion in canine ventricular midmyocytes. However, this control
is less stringent in RVMs compared to LVMs, resulting in
higher cytoplasmic cAMP ([cAMP]cyt) upon b-AR stimulation.
Regulation of Membrane cAMP, ICa,L and IKs by
PDE3 and PDE4 in RVMs and LVMs
Given the large contribution of PDE4 to cytoplasmic cAMP
hydrolysis upon b-AR stimulation, we compared the
respective roles of PDE3 and PDE4 in the b-AR regulation of
subsarcolemmal cAMP in canine ventricular myocytes. As
shown in Figure 5A, inhibition of PDE3 with 1 lmol/L Cil had
no effect on the maximal cAMP elevation at the plasma
membrane but delayed cAMP recovery in LVMs and RVMs.
Interestingly, the difference in average t1/2off values between
Iso and Iso+Cil reached statistical signiﬁcance only in LVMs
(t1/2off was 10717 seconds for Iso, and 23250 seconds
for Iso+Cil, P<0.05 whereas in RVMs, t1/2off was
11217 seconds for Iso alone and 17139 seconds for
Iso+Cil, P=0.36) suggesting a stronger contribution of mem-
brane-bound PDE3 in LVMs versus RVMs to cAMP hydrolysis
upon b-AR stimulation. In sharp contrast to what was
observed in the cytoplasm, PDE4 inhibition with Ro at
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Figure 5. Regulation of subsarcolemmal cAMP by PDE3 and PDE4 after brief b-AR stimulation. A, Left, average time course of cAMP levels
measured at the plasma membrane with pmEpac2-camps following b-AR stimulation with Iso (100 nmol/L, 15 seconds) alone (gray and black
lines, data from Figure 4A) and representative examples of the effect of the PDE3 inhibitor cilostamide (Cil, 1 lmol/L) in a LVM (white circles)
and a RVM (black circles). Right, bar graphs representing the average maximal amplitude and time to 50% recovery (t1/2off) of the sarcolemmal
cAMP transients induced by Iso alone or Iso with Cil in LVMs (n=4 from 3 dogs) and RVMs (n=5 from 2 dogs). B, Left, average time course of the
plasma membrane cAMP levels following b-AR stimulation with Iso (100 nmol/L, 15 seconds) alone (gray and black lines, data from Figure 4A)
and representative examples of the effect of the PDE4 inhibitor Ro 20-1724 (Ro, 10 lmol/L) in a LVM (white circles) and a RVM (black circles).
Right, bar graphs representing the average maximal amplitude and time to 50% recovery (t1/2off) of the cAMP transients induced by Iso alone or
Iso with Ro in LVMs (n=9 from 3 dogs) and RVMs (n=5 from 3 dogs). PDE inhibitors were added to the Iso solution and in the washout solution.
Symbols and bar graphs indicate the meanSEM. Statistical difference between Iso alone and Iso+PDE inhibitor in LVMs and RVMs is indicated
as *, P<0.05. AR indicates adrenergic; cAMP, cyclic adenosine monophosphate; Iso, isoprenaline; LV, left ventricle; LVM, left ventricular
myocyte; PDE, phosphodiesterase; RV, right ventricle; RVM, right ventricle myocyte.
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10 lmol/L had no effect, neither on the amplitude nor on the
recovery kinetics of the cAMP transient generated by Iso
pulse stimulation at the plasma membrane (Figure 5B). We
next investigated the respective contribution of PDE3 and
PDE4 to the regulation of ICa,L and IKs. As shown in Figure 6A,
PDE3 inhibition had no effect on the maximal ICa,L stimulation
induced by Iso (100 nmol/L, 15 seconds), but signiﬁcantly
delayed ICa,L recovery in LVMs and RVMs (in LVMs, t1/2off was
917 seconds for Iso, and 20322 seconds for Iso+Cil,
P<0.001; in RVMs, t1/2off was 11311 seconds for Iso alone
and 17619 seconds for Iso+Cil, P<0.05). Interestingly,
PDE3 inhibition also slowed IKs recovery in RVMs and LVMs
(data not shown). In contrast, inhibition of PDE4 with Ro at
10 lmol/L did not modify ICa,L (Figure 6B) nor IKs recovery.
However, when PDE3 was inhibited by Cil, concomitant
inhibition of PDE4 drastically prolonged the b-AR stimulation
of the current (Figure 6C), with t1/2off values reaching
38166 seconds in RVMs (P<0.05 versus Iso+Cil) and
38151 seconds in LVMs (P<0.01 versus Iso+Cil). These
results indicate that although PDE3 is dominant for b-AR
regulation of ICa,L in canine myocytes, PDE4 becomes
important when PDE3 is inhibited.
In Vivo Inotropic Response to Isoproterenol in
RV and LV
Altogether, the above results indicate that b-AR stimulation
of ECC is more efﬁcient in RVMs versus LVMs due to a
stronger contribution of compartmentalized PDE3 and PDE4
to hydrolyze cAMP in the cytoplasm. Since these results were
obtained in isolated cells, it seemed important to test
whether enhanced b-AR responsiveness could be observed at
a more integrated level. For this, pressure recordings were
obtained simultaneously from the RV and LV at baseline and
during infusion of Iso in anesthetized beagle dogs. Repre-
sentative examples relative to the ECG are shown in
Figure 7A. At baseline, systolic pressures and maximal dP/
dt were signiﬁcantly higher in the LV than in the RV
(Figure 7B). For example, maximal dP/dt was
2582194 mm Hg/s in the LV versus 53445 mm Hg/s
in the RV (P<0.001). Upon Iso, maximal dP/dt increased
3.4-fold in the LV compared with almost 5-fold in the RV
(P<0.05; Figure 7B, left panel). Accordingly, the relative
increase in systolic pressure by b-AR stimulation was
signiﬁcantly higher in the RV than LV, reaching on average
6619 mm Hg (+616%) and 17231 mm Hg (+204%),
respectively (P<0.01) during Iso (Figure 7B, right panel). In
addition, the relative increase in maximal dP/dt and systolic
pressure was more sustained in the RV than the LV after the
Iso bolus infusions (Figure 7C). Diastolic pressures did not
show discernible interventricular differences from baseline
to Iso.
Discussion
This study provides evidence that the RV is more sensitive
than the LV to b-AR stimulation, in part due to intrinsic
postsynaptic differences in myocyte b-AR signaling. The
enhanced efﬁciency of Iso to stimulate Ca2+ transients and
sarcomere shortening in RVMs compared with LVMs isolated
from the same hearts is correlated with an increased positive
inotropic effect of Iso observed in the RV in vivo. Enhanced
b-AR responsiveness in RVMs is not associated with
modiﬁcations of b-AR signaling at the plasma membrane,
since b-AR stimulation of subsarcolemmal [cAMP]i and of
membrane currents ICa,L and IKs are similar in RVMs and
LVMs, even though basal IKs density showed interventricular
differences, in agreement with our previous study.33 How-
ever, RVMs display a higher cAMP accumulation and
exacerbated PKA response in the cytoplasm compared to
LVMs, and the difference in cAMP is abolished by inhibition
of PDE3 and PDE4. Thus, PDE3 and PDE4 shape distinct
compartmentalized cAMP signals that underlie regionally
speciﬁc differences in the cardiac ventricles upon b-AR
stimulation.
Recent clinical studies indicate that during intense physical
exercise, the afterload of the RV increases more than that of
the LV.41,56 Because the sympathetic nervous system is
strongly activated during exercise, these observations suggest
that the RV could be more sensitive to sympathetic stimu-
lation than the LV in humans. Earlier studies that compared
the responsiveness of the LV versus RV to sympathetic nerve
stimulation in dogs are consistent with this notion: Norris and
Randall showed that stimulation of the left and right ansae
subclavia has a stronger inotropic effect in the RV than in the
LV.42 Similarly, Abe et al43 reported stronger effects of
sympathetic nerve stimulation on RV systolic pressure, which
were not modiﬁed by a1-AR blockade. Thus, previous data
suggested the existence of differential b-AR stimulation in RV
versus LV, but until now its clear demonstration has been
lacking and the potential mechanisms involved remain
elusive. Our experiments show that Iso infusion in vivo exerts
a stronger relative increase in RV contractility compared with
that of the LV (Figure 7). By themselves, these in vivo data do
not allow the exclusion of a differential effect of Iso on
innervations or loading conditions of the 2 ventricles.
However, consistent with our hypothesis, Piao et al, using
RV and LV Langendorff preparations in rat, have shown
recently that the inotropic effect of dobutamine is more
efﬁcient in the RV than in the LV.57 Importantly, myocytes
isolated from the midmyocardial layer of the RV showed
enhanced and prolonged stimulation of Ca2+ transients and
contraction by Iso compared to their LV counterparts
(Figure 1). These results demonstrate that the high sensitivity
of the RV to b-AR stimulation relies at least partly on an
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Figure 6. Regulation of ICa,L by PDE3 and PDE4 after brief b-AR stimulation. Average time course of ICa,L (left)
andmean values of time for 50% recovery (t1/2off) (right) in response tob-AR stimulationwith Iso (100 nmol/L,
15 seconds) alone or with A, cilostamide (Cil, 1 lmol/L; white circles: LVMs n=18 from 7 dogs; black circles:
RVMs, n=11 from 6 dogs); B, Ro 20-1724 (Ro, 10 lmol/L; white circles: RVMs, n=15 from 6 dogs; black
circles: LVMs, n=11 from 6 dogs); C, the combination of Cil and Ro (Cil+Ro, white circles: LVMs, n=11 from 2
dogs; black circles: LVMs, n=11 from 2 dogs). PDE inhibitors were added to the Iso solution and in the washout
solution. The symbols and bar graphs indicate the meanSEM. Statistical difference between Iso alone and
Iso+PDE inhibitor in LVMs and RVMs is indicated as **, P<0.01; ***, P<0.001. AR indicates adrenergic;
cAMP, cyclic adenosine monophosphate; Iso, isoprenaline; LV, left ventricle; LVM, left ventricular myocyte;
PDE, phosphodiesterase; RV, right ventricle; RVM, right ventricle myocyte.
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intrinsic property of RV myocytes, and raise the question of
which mechanisms are involved.
b-AR control of cardiac ECC operates mainly through
activation of cAMP and PKA. Consistent with increased
functional effects of b-ARs, cytoplasmic cAMP and phosphor-
ylation of a speciﬁc PKA sensor were found to be increased in
RVMs upon Iso pulse stimulation (Figure 2). While it seems
very likely that increased phosphorylation of the PKA probe
was due to enhanced PKA activity in RVMs versus LVMs, the
slower decay kinetics of AKAR-NES dephosphorylation could
also result from a lower phosphatase activity in RVMs. To the
best of our knowledge, differences in phosphatase activity
have not been documented in LV versus RV. Because we
focused on the role of phosphodiesterase and compartmen-
talization of cAMP, we did not pursue the investigation of
phosphatases. However, this point would deserve further
consideration in future studies.
Interestingly, this difference was compartment-speciﬁc
since enhanced b-AR responses were not observed at the
plasma membrane. Indeed neither b-AR regulation of subsar-
colemmal cAMP signals nor that of ICa,L and IKs were modiﬁed
in RV compared with LV (Figure 3). Since ICa,L was not
involved in the enhanced inotropic effect of Iso in RV, other
ECC proteins must be differentially regulated. Likely candi-
dates are RyR2 and PLB, which control SR Ca2+ release and
reuptake by SERCA2a, respectively. Although differential
SERCA2a-PLB association was observed in RV versus LV in
rat,39 we did not observe differences in the decay kinetics of
A
B
C
Figure 7. Differential response to b-adrenergic stimulation in the LV vs RV in anesthetized dogs.
A, Representative pressure recordings, togetherwith ECG lead II, before and60 seconds after bolus infusion of
the b-adrenergic agonist isoproterenol at 2.5 lg/kg. Representative maximal dP/dt values for LV and RV
before and after Iso are indicated in red. B, Bar graphs showing average values (N=4 dogs) for maximal dP/dt
and peak systolic pressures in the LV and RV before and after infusion of isoproterenol. C, Bar graphs
illustrating the average time courses of alterations inmaximal dP/dt and peak systolic pressures after infusion
of isoproterenol, including recovery phase. Data are shown as change from baseline. *, P<0.05. ECG indicates
electrocardiography; ICa,L, L-type Ca
2+ channel current; LV, left ventricle; RV, right ventricle.
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Ca2+ transients in RV versus LV dog myocytes (data not
shown). To our knowledge, whether RyR2 and PLB are
differentially phosphorylated in response to Iso stimulation in
RV versus LV has not been investigated.
Enhanced b-AR functional effects in RVMs could result
from increased cAMP generation in RVMs. However, the lack
of difference at the plasma membrane (Figure 3) does not
support this idea. Moreover, previous studies in dog and
humans provide compelling evidence that the density of b-
ARs, AC activity and AC stimulation by b-ARs are similar
between RV and LV.44–49 Because in rodents PDEs can
generate cAMP gradients within cardiac myocytes,8,9,58,59 we
tested the hypothesis that they could be involved in the
interventricular differences in cytoplasmic cAMP accumula-
tion in dogs. Our results indicate that PDE3 inhibition strongly
increased maximal [cAMP]cyt in LVMs upon b-AR stimulation,
while having a weak effect on maximal [cAMP]cyt in RVMs,
thus abolishing the differences between RVMs and LVMs.
PDE3 inhibition also signiﬁcantly prolonged the effect of Iso
on [cAMP]pm in LVMs but not in RVMs (Figure 6A). PDE4
inhibition potentiated the maximal [cAMP]cyt in both RVMs
and LVMs upon b-AR stimulation, with a more pronounced
effect in RVMs. As a consequence, the interventricular
difference in [cAMP]cyt accumulation was attenuated upon
PDE4 inhibition. We conclude that regionally speciﬁc differ-
ences in subcellular cAMP compartmentation arise from a
more stringent control of b-ARs cAMP signals by PDE3 and
PDE4 in LVMs than in RVMs.
Upon b-AR stimulation, the relatively balanced contribution
of PDE3 and PDE4 to cAMP hydrolysis in the cytoplasm
(Figure 4) and the dominance of PDE3 at the sarcolemma
(Figure 5) is at variance with previous results in rodents,
where PDE4 is dominant in both compartments.6–9 Because in
dog PDE3 inhibitors have strong inotropic effects in contrast
to PDE4 inhibitors,18 our results raise the question of the
functional role of PDE4 in dog. When the respective role of
these 2 PDEs was evaluated on the stimulation of ICa,L by Iso,
inhibition of PDE3 but not PDE4 signiﬁcantly prolonged ICa,L
upregulation (Figure 6). This is consistent with a predomi-
nance of PDE3 in T-tubular membranes, whereas only a
fraction of PDE4 is sarcolemmal and most of the activity is
soluble.18,19 However, when PDE3 was inhibited, PDE4
inhibition drastically prolonged ICa,L recovery from b-AR
stimulation (Figure 6). Thus, PDE4 can regulate ICa,L, but
under normal conditions it is masked by the predominant
PDE3. Therefore, the hierarchy between PDE3 and PDE4
appears to be opposite in dogs compared with rats.9
In conclusion, the current study demonstrates that RV and
LV differ in their sensitivity to b-AR stimulation both in vivo
and in vitro, and reveals regionally speciﬁc differences in b-AR
coupling to PDE3 and PDE4 and subcellular cAMP compart-
mentation in the heart. The fact that these results were
obtained in a large mammal increases the likelihood, at least
to some extent, that they represent the human situation. If
this is the case, such enhanced sensitivity to b-AR stimulation
may be an important factor for RV dysfunction not only in the
context of sports medicine, but also in RV failure consequent
to left-sided heart failure or pulmonary hypertension (PH)
where activation of the sympathetic nervous system, although
beneﬁcial on the short term, becomes detrimental for cardiac
function in the long run. In this context, our results suggest
that b-blockers could be particularly effective in right heart
failure. Consistent with this hypothesis, b-adrenoceptor
blockade was reported to prevent b-AR down-regulation and
to attenuate desensitization in experimental right heart failure
induced by progressive pulmonary artery banding and tricus-
pid avulsion in dog.48 Similarly, b-blockers were shown to
have beneﬁcial effects on RV function and morphology in rat
models of PH (reviewed in60). Interestingly, although b-
blockers are not recommended in humans with PH because of
their acute negative chronotropic and inotropic effects, low
doses of bisoprolol were shown to improve RV contractility
and ﬁlling and to delay the progression of right heart failure in
the monocrotaline rat model of PH.61 Our study also shows
that the coupling of b-AR to PDE3 and PDE4 differs in the
normal LV versus RV. It will be important in future studies to
determine whether this is related to a differential expression
and/or localization of PDE3 and PDE4 in the 2 ventricles, and
how this coupling is modiﬁed during hypertrophy and heart
failure. Indeed, whereas a decrease in b1-AR expression
is known to occur in both the failing LV and RV,45 much less
is known concerning PDE remodeling in right heart failure.
A deeper characterization of interventricular differences in
cAMP signaling compartmentation may provide new indica-
tions for therapies that preferentially target the failing RV.
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